Ferroptosis in Regulating Treatment Tolerance of Digestive System Tumors
Cancer Screening and Prevention · 25.09.2024 · 3 (3) · 163-169
DOI: 10.14218/csp.2024.00018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Screening and Prevention, online erschienen am 25.09.2024. Verfasst von Xin Quan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Among all tumors worldwide, digestive tract tumors have a higher incidence rate and a significant disease burden. Esophageal cancer, gastric cancer, liver cancer, and colorectal cancer are often diagnosed at an advanced stage, and the prognosis remains poor. Currently, tumor treatment resistance is a major global challenge, with many underlying mechanisms. Ferroptosis has been shown to reverse drug resistance. This article reviews the mechanisms and recent advancements in ferroptosis related to reversing treatment resistance in gastrointestinal tumors, aiming to provide theoretical insights and research directions for the diagnosis and treatment of digestive tract tumors.
Zitieren
APA
Quan, X., Wen, H., Liang, H., & Zhang, M. (2024). Ferroptosis in Regulating Treatment Tolerance of Digestive System Tumors. Cancer Screening and Prevention, 3(3), 163-169. https://doi.org/10.14218/csp.2024.00018
Vancouver
Quan X, Wen H, Liang H, Zhang M. Ferroptosis in Regulating Treatment Tolerance of Digestive System Tumors. Cancer Screening and Prevention. 2024;3(3):163-169. doi:10.14218/csp.2024.00018
BibTeX
@article{Quan2024,
author = {Quan, Xin and Wen, Hua and Liang, Hao and Zhang, Mingxin},
title = {Ferroptosis in Regulating Treatment Tolerance of Digestive System Tumors},
journal = {Cancer Screening and Prevention},
year = {2024},
volume = {3},
number = {3},
pages = {163--169},
doi = {10.14218/csp.2024.00018}
}
EUVIMED